| Colorectal cancer liver metastasis: evolving paradigms and future directions LR Zarour, S Anand, KG Billingsley, WH Bisson, A Cercek, MF Clarke, ... Cellular and molecular gastroenterology and hepatology 3 (2), 163-173, 2017 | 276 | 2017 |
| Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival CE Gast, AD Silk, L Zarour, L Riegler, JG Burkhart, KT Gustafson, ... Science advances 4 (9), eaat7828, 2018 | 232 | 2018 |
| Macrophage-dependent cytoplasmic transfer during melanoma invasion in vivo M Roh-Johnson, AN Shah, JA Stonick, KR Poudel, J Kargl, GH Yang, ... Developmental cell 43 (5), 549-562. e6, 2017 | 118 | 2017 |
| Relevance of circulating hybrid cells as a non-invasive biomarker for myriad solid tumors MS Dietz, TL Sutton, BS Walker, CE Gast, L Zarour, SK Sengupta, ... Scientific Reports 11 (1), 13630, 2021 | 37 | 2021 |
| Emerging therapies in castrate-resistant prostate cancer L Zarour, J Alumkal Current urology reports 11, 152-158, 2010 | 25 | 2010 |
| A DNA methylation microarray-based study identifies ERG as a gene commonly methylated in prostate cancer J Schwartzman, S Mongoue-Tchokote, A Gibbs, L Gao, CL Corless, J Jin, ... Epigenetics 6 (10), 1248-1256, 2011 | 19 | 2011 |
| Circulating hybrid cells: a novel liquid biomarker of treatment response in gastrointestinal cancers BS Walker, TL Sutton, L Zarour, JG Hunter, SG Wood, VL Tsikitis, ... Annals of surgical oncology 28 (13), 8567-8578, 2021 | 15 | 2021 |
| Hepatic resection of solitary HCC in the elderly: A unique disease in a growing population LR Zarour, KG Billingsley, BS Walker, CK Enestvedt, SL Orloff, E Maynard, ... The American Journal of Surgery 217 (5), 899-905, 2019 | 11 | 2019 |
| Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv 4 (9): eaat7828 CE Gast, AD Silk, L Zarour, L Riegler, JG Burkhart, KT Gustafson, ... | 6 | 2018 |
| Cell fusion potentiates tumor heterogeneity and reveals circulating hybrid cells that correlate with stage and survival. Sci Adv. 2018; 4: eaat7828 CE Gast, AD Silk, L Zarour, L Riegler, JG Burkhart, KT Gustafson, ... | 6 | |
| Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established program BS Walker, KG Billingsley, TL Sutton, KJ Kolbeck, EK Korngold, ... Journal of surgical oncology 126 (3), 513-522, 2022 | 4 | 2022 |
| Stem cell marker expression in early stage colorectal cancer is associated with recurrent intestinal neoplasia BS Walker, LR Zarour, N Wieghard, AC Gallagher, JR Swain, ... World journal of surgery 44, 3501-3509, 2020 | 3 | 2020 |
| Use of circulating cancer cell hybrids to monitor treatment response to hepatic arterial infusion in patients with colorectal cancer metastatic to the liver L Zarour, J Swain, K Billingsley, C Lopez, G Vaccaro, N Nabavizadeh, ... HPB 20, S352, 2018 | 2 | 2018 |
| ASO Visual Abstract: Circulating Hybrid Cells—A Novel Liquid Biomarker of Treatment Response in Gastrointestinal Cancers BS Walker, TL Sutton, Z Luai, JG Hunter, SG Wood, TV Liana, DO Herzig, ... Annals of surgical oncology 28, 577-578, 2021 | | 2021 |
| The True Extent of Biliary Toxicity from Hepatic Arterial Infusion: A Plea for a Standardized Definition BS Walker, KG Billingsley, TL Sutton, LR Zarour, KJ Kolbeck, EK Korngold, ... ANNALS OF SURGICAL ONCOLOGY 27 (SUPPL 1), S83-S83, 2020 | | 2020 |
| Saphenous venous cavernous angioma masquerading as an aneurysm L Zarour, AJ Cunningham, MA Jafri Journal of Pediatric Surgery Case Reports 50, 101306, 2019 | | 2019 |
| Hepatic Resection of Solitary HCC in the Elderly: Disease Control and Survival in a Growing Population L Zarour, KG Billingsley, W Naugler, CK Enestvedt, SL Orloff, E Maynard, ... ANNALS OF SURGICAL ONCOLOGY 25, S128-S128, 2018 | | 2018 |
| A microarray-based study of DNA methylation changes in prostate cancer J Schwartzman, S Mongoue-Tchokote, L Zarour, A DeMarzo, GS Bova, ... Cancer Research 70 (8_Supplement), 144-144, 2010 | | 2010 |
Skye C. MayoHepatopancreatobiliary Surgical Oncologist, Knight Cancer Institute at Oregon Health & ScienceVerified email at ohsu.edu
